Yuliya V. Oleinik

Yuliya V. Oleinik

Auto-generated profile, based on publicly available information

Yuliya V. Oleinik

Vreden National Medical Research Center of Traumatology and Orthopedics

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2024 in Traumatology and Orthopedics of Russia
Verified
Journal Article
Open access
SBSvetlana Bozhkova
Svetlana Bozhkova
YOYuliya V. Oleinik
Yuliya V. Oleinik
VAVasily A. Artyukh
Vasily A. Artyukh
AAAlexander P. Antipov
Alexander P. Antipov
STSergey S. Toropov
Sergey S. Toropov
АИАстахов Денис Игоревич
Астахов Денис Игоревич
Background. The most common method of treatment of chronic periprosthetic joint infection (PJI) is considered to be a two-stage revision arthroplasty. The efficacy of this technique is largely determined by the results of infection management after the first (debridement) stage, which may depend on many factors. At the same time, the widespread tendency to reduce the duration of patients’ hospital stay brings to the forefront the problem of long wait for the results of preoperative microbiological examination. Aims of the study: 1) to retrospectively evaluate the efficacy of the debridement stage of chronic periprosthetic hip joint infection in 2021 depending on the availability of preoperative microbiological examination results; 2) to determine the factors influencing the treatment outcome. Methods. Patients (n = 86) with chronic PJI of the hip were allocated into two groups depending on the presence or absence of results of the microbiological examination of preoperative biomaterials (aspirate and/or tissue biopsy) at the time of performing the first stage of the two-stage revision arthroplasty. Results. The availability of final results of the microbiological examination (MBE) of joint aspirate at the time of surgery had no significant effect on the efficacy of infection management (p = 0.536; OR = 1.53, 95% CI 0.43-5.45). There was a significant reduction of the risk when the results of preoperative and intraoperative MBE coincided (p = 0.024; OR = 0.121, 95% CI 0.015-0.990). An increased risk of adverse outcome of the debridement stage of treatment was observed in the case of types 2C (p = 0.042; OR = 6.66; 95% CI 1.26-35.2) and 3B (p = 0.078; OR = 8.1, 95% CI 1.015-64.8) acetabular defects, type 3A femoral defects (p = 0.021; OR = 6.57, 95% CI 1.49-29.01), and connective tissue diseases (p = 0.062; OR = 5.25, 95% CI 1.05-26.2). The presence of microbial associations (p=0.02; OR = 6.75, 95% CI 1.36-33.44) and the presence of Gram-negative bacteria in them (p = 0.058; OR = 4.2, 95% CI 1.02-17.20) significantly worsened the treatment prognosis. As the number of patient’s risk factors increased, the probability of an unfavorable outcome increased significantly (p0.001). Conclusion. Polymicrobial infection, presence of Gram-negative bacteria in microbial associations, connective tissue diseases, types 2C and 3B acetabular defects, type 3A femoral bone defects, and total number of risk factors in one patient had a significant negative impact on the outcome of debridement surgery. Apparently, the results of the microbiological examination of preoperatively sampled biomaterials are much more important as a diagnostic criterion for suspected periprosthetic infection than as a criterion for the drug choice for etiotropic antibacterial therapy. However, this assumption should be studied on a larger sample of patients.

21 October 2025 in Genij Ortopedii
Verified
Journal Article
Open access
PDF file
YOYu. V. Oleinik
Yu. V. Oleinik
SBSvetlana Bozhkova
Svetlana Bozhkova
ЮОЮ. В. Олейник
Ю. В. Олейник
Introduction Periprosthetic infection is one of the most frequent and devastating complications after total hip replacement. The effectiveness of infection management depends on possibility of prescribing etiotropic antibiotics after the operation and the rational choice of a surgical technique. In 5–30 % of all patients the etiology of the infectious process remains unknown throughout the entire treatment period. Such cases are described by the term "culture-negative periprosthetic joint infection". Nowaday, there is no single definition for culture-negative PJI in the professional community. The aim of this study is to evaluate the treatment results of patients with culture-negative periprosthetic infection, depending on the approach to its detection, as well as formulate possible ways to reduce its rates. Methods Literature search was performed in electronic databases eLIBRARY, PubMed (MEDLINE), ScienceDirect, Google Scholar according to PRISMA recommendations. The study included articles in Russian and English, original articles and case series on the treatment of chronic culture-negative periprosthetic infection of the hip joint and/or knee joints in patients over 18 years of age using any surgical operations and in which there was at least one indicator of treatment effectiveness. The existing approaches to detection of culture-negative periprosthetic joint infection of the knee and hip and the outcomes of treatment of patients with this pathology were analyzed, as well as possible ways to reduce the number of patients with an unknown etiology of the infectious process were formulated. Results and Discussion Our analysis of scientific publications revealed no clear difference in the effectiveness of infection control depending on the approach to detection of culture-negative PJI. For the first time, the effectiveness of treatment for patients with culture-negative PJI is examined depending on the approach to detection of this pathology. Significant heterogeneity was identified in both the interpretation of culture‑negative PJI and the choice of surgical techniques. The high rate of successful outcomes indicates the importance of appropriate selection of drugs for empirical antibiotic therapy (ABT) and regular monitoring of the spectrum of nosocomial pathogens. Potential ways to reduce the incidence of negative microbiological test results are proposed. Conclusion The efficacy of treatment of culture-negative PJI did not differ significantly depending on the interpretation of this term. Ways to reduce the incidence of this pathology are aimed at modifying the factors that cause negative results of MBI of biomaterial samples and removed structures.

7 May 2026 in Traumatology and Orthopedics of Russia
Verified
Journal Article
Open access
PDF file
YOYuliya V. Oleinik
Yuliya V. Oleinik
SBSvetlana Bozhkova
Svetlana Bozhkova
VAVasilii A. Artyukh
Vasilii A. Artyukh
AAAlexander P. Antipov
Alexander P. Antipov
STSergei S. Toropov
Sergei S. Toropov
АААртюх Василий Алексеевич
Артюх Василий Алексеевич
Background. Traditionally, single-stage revision arthroplasty was recommended only for a very limited cohort of patients. However, in the last decade, a global trend towards expanding the indications for this surgical option can be observed. The need to reduce the hospital costs for the treatment of periprosthetic joint infection (PJI) often leads to the shortening of preoperative period by refusing to wait for the results of microbiological investigation (MBI). The aim of the study — to evaluate the effectiveness of single-stage revision arthroplasty in patients with chronic periprosthetic hip infection, depending on the presence or absence of relative contraindications to this procedure. Methods. The study included 40 patients with chronic hip PJI who underwent surgical treatment between January 2022 and May 2024. After obtaining biomaterials (aspiration and/or tissue biopsies), preliminary MBI results were awaited within 5 days. After that, the patients were allocated into two groups. Group 1 included patients in whom a single strain of Gram-positive bacteria was isolated, Group 2 — patients in whom no pathogen growth was detected, or in whom polymicrobial associations or Gram-negative bacterial strains were identified. In Group 1, surgery was performed only after the final MBI results were available, whereas in Group 2, the final results were not awaited. All patients underwent single-stage revision arthroplasty, and local antibacterial therapy was performed within 3 days after surgery. The follow-up period for the cohort was no less than 24 months. Results. Periprosthetic joint infection was successfully managed in 97.5% of cases (n = 39). The following relative contraindications to single-stage revision arthroplasty were identified: data on the pathogen and its antibiotic susceptibility were unavailable at the time of surgery in 67.5% of patients, 37.5% had a functioning fistulous tract, 27.5% had recurrent PJI, and 5% — massive acetabular defects (Paprosky type 3B) along with multiple prior debridement procedures. No impaired kidney function, adverse local or systemic reactions were observed during local antibacterial therapy. Conclusions. With effective local antibacterial therapy, the indications for single-stage revision arthroplasty can be expanded, and the procedure can be successfully performed — even in the absence of data on the causative pathogen at the time of surgery. However, the following conditions remain essential for performing a single-stage procedure: absence of severe comorbidities, as well as extensive soft-tissue and/or bone defects, and the feasibility of administering local therapy in the early postoperative period along with prolonged systemic oral antibiotic therapy.